Neuroleptic malignant syndrome after haloperidol therapy.
A well documented case of neuroleptic malignant syndrome is reported. The patient had unusual, life-threatening complications, consisting of cardiac arrhythmia, followed by cardiac arrest, dysphagia persisting for eight weeks and leading to aspiration pneumonia, seizures, and myoclonus following treatment with haloperidol. An 18-month outpatient follow-up has failed to reveal any residual neurologic or cardiovascular damage.
D003680:Deglutition Disorders / Q000139:chemically induced*; D006220:Haloperidol / Q000009:adverse effects*; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000139:chemically induced*; D011015:Pneumonia, Aspiration / Q000139:chemically induced; D011618:Psychotic Disorders / Q000188:drug therapy; D012640:Seizures / Q000139:chemically induced*; D013577:Syndrome
D006220:Haloperidol